United States · Venture startup

Who invested in Cognigenics

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Genomics

Funding summaryUpdated 26 Oct 2026

Undisclosedraised across 1 round since 2025, from 1 source

Latest round
VentureFeb 2025
Investors
0
See who backed them

The rounds

  1. Feb 2025
    VentureAmount undisclosed

    No investor was named in the report.

    Source recorded

Founders and team

From the SEC filings it signed: 3 on the team.

  • Barry LinderMr. Linder is a promoter, director and officer of the company.i
  • Dean RadinMr. Radin is a promoter, director and officer of the company.i
  • John MeeMr. Mee is a promoter, director and officer of the company.i

Also claim to have backed them

This firm lists Cognigenics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

DecentraNetVC firmPer its own site

Quick answers about Cognigenics

How much has Cognigenics raised?

Cognigenics has raised 1 round since 2025, none with a disclosed amount.

When did Cognigenics last raise?

Cognigenics's most recent round was a Venture in Feb 2025.

What stage is Cognigenics at?

Cognigenics's latest named round is a Venture, in Feb 2025.

Where is Cognigenics based?

Cognigenics is based in the United States.

Companies like Cognigenics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.